Evaluating the safety and therapeutic efficacy of intravenous hydrogen nanobubble infusions in a hypercholesterolemic rat model
Aditya Tri Hernowo, Sri Widyarti, Sherry Aristyani · Berkala Penelitian Hayati · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In male Wistar rats, the administration of HNB did not adversely affect the immediate survival of the rats on a high-fat diet (HFD), whereas simvastatin significantly reduced survival rates. These preclinical findings add evidence about the molecular-hydrogen effects, outcomes, and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in male Wistar rats. The administration of HNB did not adversely affect the immediate survival of the rats on a high-fat diet (HFD), whereas simvastatin significantly reduced survival rates.
What the Researchers Studied
The researchers studied male Wistar rats. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
In this study, hypercholesterolemia male Wistar rats were utilized to investigate the safety and efficacy of intravenous hydrogen nanobubble solution (HNB). The administration of HNB did not adversely affect the immediate survival of the rats on a high-fat diet (HFD), whereas simvastatin significantly reduced survival rates. The authors concluded that hNB may serve as a protective agent against the deleterious effects of a high-fat diet, offering immunomodulatory and hepatoprotective benefits.
Why These Findings Matter
This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was male Wistar rats. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.